Search

Your search keyword '"Elena Guerini Rocco"' showing total 175 results

Search Constraints

Start Over You searched for: Author "Elena Guerini Rocco" Remove constraint Author: "Elena Guerini Rocco" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
175 results on '"Elena Guerini Rocco"'

Search Results

1. Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience

2. Liquid biopsy: Cell-free DNA based analysis in breast cancer

3. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations

4. Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study

5. Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence

6. Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study

7. Author Correction: A role for the immune system in advanced laryngeal cancer

8. Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients

9. Digital slides as an effective tool for programmed death ligand 1 combined positive score assessment and training: Lessons learned from the 'Programmed death ligand 1 key learning program in Head-and-Neck squamous cell carcinoma'

10. Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles

12. The molecular landscape of breast mucoepidermoid carcinoma

13. Abstract P2-21-04: The tumor immune microenvironment composition and prognostic value in breast cancer during pregnancy is dynamic during the gestation period

14. Successful treatment with avapritinib in patient with mucosal metastatic melanoma

15. Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up

16. Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial

17. In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay

20. Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test

21. Abstract P3-18-08: Feasibility and safety of breast-conserving surgery in early-stage breast cancers during the first trimester of pregnancy

22. Abstract P1-22-03: Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ

23. Abstract P4-07-02: Tumor microenvironment characteristics and prognosis in breast cancer during pregnancy: The role of differentially expressed immune-related genes

24. Abstract P4-10-23: Combined analysis of PTEN and routinely assessed biomarkers reveals new high-risk subgroups of HR- or HER2+ breast cancers

25. Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

26. Supplementary Tables S1-S3 from The Genomic Landscape of Male Breast Cancers

27. Table S1 from Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial

28. Supplementary Methods from The Genomic Landscape of Male Breast Cancers

29. Figure S2 from Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial

30. Supplementary Figure 1 from PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

31. Supplementary Data from Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

32. Supplementary Table 1 from PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

33. Data from Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial

34. Supplementary Figures S4 and S5 from The Genomic Landscape of Male Breast Cancers

35. Data from Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

36. Data from PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

37. Supplementary Tables S11 and S12 from The Genomic Landscape of Male Breast Cancers

38. Data from The Genomic Landscape of Male Breast Cancers

39. Supplementary Figures S1-S3 from The Genomic Landscape of Male Breast Cancers

40. Supplementary Table 2 from PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

41. Supplementary Table 3 from PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

42. Germline pathogenic variants in metaplastic breast cancer patients: a monocentric study and literature review

44. In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study

45. 2022-RA-659-ESGO The role of molecular classification in endometrial cancers with lymph nodes metastasis

46. 2022-RA-376-ESGO Clinicopathological characteristics of ‘multiple-classifiers’ in endometrial cancer

47. Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review

48. Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for

49. HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes

50. Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages

Catalog

Books, media, physical & digital resources